Mitch Murdock, Ph.D.

Mitch is an Equity Research Associate on TimesSquare’s U.S. Equity Team and is responsible for investment analysis of the biotechnology sector. He joined TimesSquare in 2026 from Truist Securities, where he worked as a Senior Associate covering biotechnology, with prior experience at Goldman Sachs and SV Health Investors. He completed his postdoctoral studies at MIT and worked as a researcher at Weill Cornell Medical College. He holds a B.S. in Molecular Biology and a B.A. in English from Yale University and a Ph.D. in Neuroscience from the Massachusetts Institute of Technology (MIT).